Navigating choices: understanding the decision‐making journey of patients with localised kidney cancer
BJU International · 2025
DOI: 10.1111/bju.16635 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJU International, 2025. Verfasst von Katharina Beyer und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Erasmus MC Cancer Institute Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Kidney Neoplasms, Patient Participation, Decision Making. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Royal Marsden Cancer Charity, Kidney Cancer UK.
Abstract (Originalsprache)
Objective
To explore patients’ experience of decision making regarding treatment of localised kidney cancer.
Methods
A total of 21 patients with localised kidney cancer, across three countries, participated in either four focus groups or seven semi‐structured interviews that lasted on average 2 h. Focus groups and interviews were all conducted in the participants' native language, recorded, transcribed and (if applicable) translated into English. Thematic analysis was used to develop a codebook and identify themes.
Results
All participants expressed a desire to be actively involved in the treatment decision‐making process. However, due to the emotional toll of the cancer journey, which often necessitates quick decisions, actively engaging in the decision‐making process was described as challenging. The study revealed 12 key themes. These themes included the impact of diagnostic paths, patient characteristics, patient empowerment, health literacy, source of support, fear of recurrence, trust in treatment and healthcare providers, shared decision making (SDM), professional interaction, personal belief system, and organisational and administrative issues.
Conclusions
The findings highlight the complexity of decision making, underscoring the desire for patient involvement, SDM, and clear communication. We reveal a significant gap between research recommendations and clinical practice, emphasising the need to translate research findings to clinical application to enhance patient‐centred care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Erasmus MC Cancer Institute Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.
- Translational Oncology and Urology Research (TOUR), King's College London, London, UK.
- Department of Endocrine Oncology, Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands.
- Specialist Centre for Kidney Cancer, Royal Free Hospital, London, UK.
- Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, Medical University of Innsbruck, Innsbruck, Austria.
- International Kidney Cancer Coalition, Utrecht, The Netherlands.
ORCID-Profile: Katharina Beyer, Lionne D F Venderbos, Monique J Roobol, Mieke Van Hemelrijck
Förderung
- Royal Marsden Cancer Charity
- Kidney Cancer UK
Zitieren
APA
Beyer, K., Venderbos, L. D. F., Roobol, M. J., Giles, R. H., Verhagen, P., Barod, R., Wintner, L. M., Jewett, M. A. S., Van Hemelrijck, M., & Kinsella, N. (2025). Navigating choices: understanding the decision‐making journey of patients with localised kidney cancer. BJU International. https://doi.org/10.1111/bju.16635
Vancouver
Beyer K, Venderbos LDF, Roobol MJ, Giles RH, Verhagen P, Barod R, et al. Navigating choices: understanding the decision‐making journey of patients with localised kidney cancer. BJU International. 2025. doi:10.1111/bju.16635
BibTeX
@article{Beyer2025,
author = {Beyer, Katharina and Venderbos, Lionne D F and Roobol, Monique J and Giles, Rachel H and Verhagen, Paul and Barod, Ravi and Wintner, Lisa M and Jewett, Michael A S and Van Hemelrijck, Mieke and Kinsella, Netty},
title = {Navigating choices: understanding the decision‐making journey of patients with localised kidney cancer},
journal = {BJU International},
year = {2025},
doi = {10.1111/bju.16635}
}
EUVIMED